Company Filing History:
Years Active: 2019-2024
Title: Yawu Jing: Innovator in Engineered CD16 Technologies
Introduction
Yawu Jing is a prominent inventor based in Shoreview, MN (US). He has made significant contributions to the field of biotechnology, particularly in the development of engineered CD16 technologies. With a total of 3 patents to his name, Jing's work focuses on enhancing anti-tumor and anti-viral activities through genetic modifications.
Latest Patents
Jing's latest patents include innovative methods involving polypeptides and genetically-modified cells that express a modified form of CD16. This modified CD16 exhibits increased anti-tumor and anti-viral activity, primarily due to its reduced susceptibility to ADAM17-mediated shedding upon NK cell stimulation. These advancements hold promise for improving therapeutic strategies in cancer and viral infections.
Career Highlights
Yawu Jing is affiliated with the University of Minnesota, where he conducts his research and development activities. His work has garnered attention for its potential applications in medical science, particularly in immunotherapy.
Collaborations
Jing collaborates with notable colleagues, including Bruce Kenneth Walcheck and Dan Samuel Kaufman. Their combined expertise contributes to the advancement of research in engineered cell technologies.
Conclusion
Yawu Jing's innovative work in the field of biotechnology, particularly with engineered CD16, showcases his commitment to advancing medical science. His contributions are paving the way for new therapeutic approaches in combating diseases.